Importance of Developing New Tools to Assess Cardiac Amyloidosis Using Echocardiography.
作者信息
Mesquita Claudio Tinoco, Costa Andréa Rodrigues da, Saraiva Roberto Magalhães
机构信息
Antonio Pedro University Hospital, Fluminense Federal University, Niterói, Brazil.
Clinical Research Laboratory in Chagas Disease, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
出版信息
Echocardiography. 2025 Aug;42(8):e70271. doi: 10.1111/echo.70271.
Abstract
摘要
相似文献
1
Importance of Developing New Tools to Assess Cardiac Amyloidosis Using Echocardiography.开发利用超声心动图评估心脏淀粉样变性的新工具的重要性。
Echocardiography. 2025 Aug;42(8):e70271. doi: 10.1111/echo.70271.
2
Echocardiographic Characterization of Myocardial Stiffness in Healthy Volunteers, Cardiac Amyloidosis, and Hypertrophic Cardiomyopathy: A Case-Control Study Using Multimodality Imaging.健康志愿者、心脏淀粉样变性和肥厚型心肌病中心肌僵硬度的超声心动图特征：一项使用多模态成像的病例对照研究
Circ Cardiovasc Imaging. 2025 Mar;18(3):e017475. doi: 10.1161/CIRCIMAGING.124.017475. Epub 2025 Mar 3.
3
When is imaging needed to assess the response to treatment in cardiac amyloidosis.何时需要进行成像检查以评估心脏淀粉样变性的治疗反应。
Curr Opin Cardiol. 2025 Sep 1;40(5):335-342. doi: 10.1097/HCO.0000000000001236. Epub 2025 May 21.
4
Differentiation and correlation of regional uptake heterogeneity with cardiac dysfunction in biopsy-proven transthyretin amyloid cardiomyopathy using quantitative single-photon emission computed tomography/computed tomography: a single-center, cross-sectional study.使用定量单光子发射计算机断层扫描/计算机断层扫描对经活检证实的转甲状腺素蛋白淀粉样心肌病中区域摄取异质性与心脏功能障碍进行鉴别和相关性分析：一项单中心横断面研究。
EJNMMI Res. 2025 Aug 1;15(1):97. doi: 10.1186/s13550-025-01292-w.
5
Echocardiographic Nomogram Model: A Tool for Assessing Cardiac Involvement in Patients With Systemic Amyloidosis.超声心动图列线图模型：一种评估系统性淀粉样变性患者心脏受累情况的工具。
Echocardiography. 2025 Aug;42(8):e70252. doi: 10.1111/echo.70252.
6
Feasibility of the absolute quantification and left ventricular segmentation of cardiac sympathetic innervation in wild-type transthyretin amyloidosis cardiomyopathy with [I]-MIBG SPECT/CT: The I-NERVE study.利用[I]-间碘苄胍单光子发射计算机断层显像/计算机断层扫描对野生型转甲状腺素蛋白淀粉样变性心肌病心脏交感神经支配进行绝对定量和左心室分割的可行性：I-NERVE研究
J Nucl Cardiol. 2025 Mar;45:102146. doi: 10.1016/j.nuclcard.2025.102146. Epub 2025 Feb 3.
7
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With Cardiomyopathy.维特西瑞对转甲状腺素蛋白淀粉样变心肌病患者心脏功能及预后的影响
J Am Coll Cardiol. 2025 Aug 12;86(6):444-455. doi: 10.1016/j.jacc.2025.06.022.
8
Wild-type transthyretin cardiac amyloidosis: a case of multisystemic involvement and review of literature.野生型转甲状腺素蛋白心脏淀粉样变性：一例多系统受累病例及文献综述
Rom J Morphol Embryol. 2025 Apr-Jun;66(2):279-289. doi: 10.47162/RJME.66.2.02.
9
Usefulness of STREI: A new index of right heart function in patients with immunoglobulin light chain cardiac amyloidosis.STREI的实用性：免疫球蛋白轻链型心脏淀粉样变性患者右心功能的新指标
Int J Cardiol. 2025 Nov 15;439:133646. doi: 10.1016/j.ijcard.2025.133646. Epub 2025 Jul 22.
10
Navigating Diagnostic Ambiguities in Cardiac Amyloidosis: Insights from a Case with Delayed Diagnosis of AL Amyloidosis.心脏淀粉样变性诊断中的模糊性解析：一例AL型淀粉样变性延迟诊断病例的启示
Am J Case Rep. 2025 Jul 4;26:e948092. doi: 10.12659/AJCR.948092.
本文引用的文献
1
Echocardiographic Nomogram Model: A Tool for Assessing Cardiac Involvement in Patients With Systemic Amyloidosis.超声心动图列线图模型：一种评估系统性淀粉样变性患者心脏受累情况的工具。
Echocardiography. 2025 Aug;42(8):e70252. doi: 10.1111/echo.70252.
2
Patisiran Treatment in the Brazilian Subpopulation of the Phase 3 APOLLO-B Study in Transthyretin Amyloidosis with Cardiomyopathy: Post Hoc Analysis.在转甲状腺素蛋白淀粉样变性心肌病3期APOLLO - B研究的巴西亚组人群中进行的帕替西兰治疗：事后分析。
Arq Bras Cardiol. 2025 Mar;122(4):e20240568. doi: 10.36660/abc.20240568.
3
Advances and challenges in echocardiographic diagnosis and management of cardiac amyloidosis.心脏淀粉样变性的超声心动图诊断与管理的进展及挑战
Int J Cardiovasc Imaging. 2025 Feb 26. doi: 10.1007/s10554-025-03362-5.
4
Cardiac Amyloidosis.心脏淀粉样变性
Ann Intern Med. 2023 Mar;176(3):ITC33-ITC48. doi: 10.7326/AITC202303210. Epub 2023 Mar 14.
5
Practical Points for Echocardiography in Cardiac Amyloidosis.心脏淀粉样变超声心动图检查的实用要点
J Am Soc Echocardiogr. 2022 Sep;35(9):A31-A40. doi: 10.1016/j.echo.2022.06.006.
6
Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.射血分数保留的心脏轻链淀粉样变性中左心房力学的预后价值：一项队列研究。
BMC Cardiovasc Disord. 2022 Apr 15;22(1):175. doi: 10.1186/s12872-022-02589-7.
7
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis.多腔室斑点追踪成像及左心房应变对心脏淀粉样变的诊断价值。
Eur Heart J Cardiovasc Imaging. 2022 Dec 19;24(1):130-141. doi: 10.1093/ehjci/jeac057.
8
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
9
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.达雷妥尤单抗治疗免疫球蛋白轻链淀粉样变性。
N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631.
10
Diagnostic imaging of cardiac amyloidosis.心脏淀粉样变性的诊断影像学。
Nat Rev Cardiol. 2020 Jul;17(7):413-426. doi: 10.1038/s41569-020-0334-7. Epub 2020 Feb 10.
Zotero 插件